KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

Biotechnology

Healthcare
$27.00 +0.00%

+$0.00 today

Market cap
$1.44B
Beta
-0.11
P/E (TTM)
-9.9
EPS (TTM)
-$2.74
52W Low $9.83High $27.00

Volume 4.26M

Average 3.47M

Balance Sheet

Inspect the capital base behind the business.

Assets

$335.38M

FY 2026 · Annual

+33.7% YoY

Liabilities

$338.09M

FY 2026 · Annual

+117.6% YoY

Equity

-$2.71M

FY 2026 · Annual

Balance Sheet

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Dec 2025
Cash & Equivalents30.73M56.24M31.79M98.64M229.34M
Short-term Investments135.47M93.14M178.61M89M70.87M
Net Receivables16.81M18.64M10.87M15.14M11.3M
Inventory00003.43M
Other Current Assets00019.21M0
Total Current Assets193.65M172.33M225.69M241.69M320.15M
Property, Plant & Equipment (Net)10.04M10.77M9.15M1.99M12.86M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets193K106K567K7.09M2.37M
Total Non-current Assets10.23M10.88M9.71M9.08M15.23M
Total Assets203.88M183.2M235.4M250.77M335.38M
Account Payables3.64M4.82M9.11M4.88M8.27M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00011M0
Other Current Liabilities4.17M4.21M6.69M036.8M
Total Current Liabilities11.58M15.03M22.81M45.17M57.36M
Long-term Debt0000139.23M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000105.88M11.71M
Other Non-current Liabilities0000119.06M
Total Non-current Liabilities7.21M7.15M6.02M110.21M280.73M
Total Liabilities18.79M22.18M28.82M155.38M338.09M
Common Stock25K34K42K50K51K
Retained Earnings(250.18M)(343.08M)(469.73M)(653.17M)(762.69M)
Accumulated OCI(3.86M)(3.06M)(3.49M)(5.21M)(7.13M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity185.09M161.03M206.58M95.39M(2.71M)
Total Debt8.19M8.23M7.32M6.31M151.58M
Net Debt(22.54M)(48.01M)(24.47M)(92.34M)(77.77M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$229.3M
Short-term Investments$70.9M
Receivables$11.3M
Inventory$3.4M
Other Current$5.2M
Total Current Assets$320.1M
PP&E (Net)$12.9M
Other Non-current$2.4M
Total Non-current Assets$15.2M
Total Assets$335.4M

Analysis

Selected assets total $335.4M for Latest. The largest visible component is Cash & Equivalents at $229.3M, about 68.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportJun 11, 2026
4Statement of changes in beneficial ownershipJun 11, 2026
4Statement of changes in beneficial ownershipJun 11, 2026
4Statement of changes in beneficial ownershipJun 11, 2026
4Statement of changes in beneficial ownershipJun 11, 2026

How much cash does KALV have?

KalVista Pharmaceuticals, Inc. (KALV) reported $229.34M in cash and equivalents in fiscal 2026.

How much debt does KALV carry?

KalVista Pharmaceuticals, Inc. (KALV) reported $151.57M of total debt, with net debt of -$77.77M.